463 related articles for article (PubMed ID: 25416694)
1. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T
Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients.
Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Navabi SJ; Shakiba E; Hassanzadeh N; Pourmotabbed T
Lupus; 2012 May; 21(6):616-24. PubMed ID: 22323339
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin type 1 receptor A1166C polymorphism and systemic lupus erythematosus: correlation with cellular immunity and oxidative stress markers.
Baniamerian H; Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Pourmotabbed T
Lupus; 2017 Dec; 26(14):1534-1539. PubMed ID: 28530466
[TBL] [Abstract][Full Text] [Related]
5. Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
Tanhapour M; Miri A; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Pourmotabbed T; Shakiba E
Clin Rheumatol; 2018 Apr; 37(4):971-977. PubMed ID: 29273831
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase (PON1) 55 polymorphism and association with systemic lupus erythematosus.
Bahrehmand F; Vaisi-Raygani A; Ahmadi R; Kiani A; Rahimi Z; Tavilani H; Pourmotabbed T
Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):211-9. PubMed ID: 23893804
[TBL] [Abstract][Full Text] [Related]
7. Association between the cytotoxic T-lymphocyte antigen-4 mutations and the susceptibility to systemic lupus erythematosus; Contribution markers of inflammation and oxidative stress.
Tanhapour M; Vaisi-Raygani A; Bahrehmand F; Khazaei M; Kiani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):56-61. PubMed ID: 27894401
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-9 promoter polymorphisms in Korean patients with systemic lupus erythematosus.
Lee YJ; Woo M; Nam JH; Baek J; Im CH; Lee EY; Lee EB; Park KS; Song YW
Hum Immunol; 2008 Jun; 69(6):374-9. PubMed ID: 18571010
[TBL] [Abstract][Full Text] [Related]
9. Role of polymorphisms in MMP-9 and TIMP-1 as biomarkers for susceptibility to systemic lupus erythematosus patients.
Vira H; Pradhan V; Umare V; Chaudhary A; Rajadhyksha A; Nadkar M; Ghosh K; Nadkarni A
Biomark Med; 2019 Jan; 13(1):33-43. PubMed ID: 30561224
[TBL] [Abstract][Full Text] [Related]
10. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
11. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
Chang YH; Lin IL; Tsay GJ; Yang SC; Yang TP; Ho KT; Hsu TC; Shiau MY
Clin Biochem; 2008 Aug; 41(12):955-9. PubMed ID: 18471998
[TBL] [Abstract][Full Text] [Related]
12. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
13. Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and Activities with Coronary Artery Calcification (CAC) in an Iranian Population.
Elahirad S; Elieh Ali Komi D; Kiani A; Mohammadi-Noori E; Vaisi-Raygani A; Mozafari H; Bahrehmand F; Saidi M; Toupchi-Khosroshahi V; Salehi N
Cardiovasc Toxicol; 2022 Feb; 22(2):118-129. PubMed ID: 34731407
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-7 A-181G and its interaction with matrix metalloproteinase-9 C-1562T polymorphism in preeclamptic patients: association with malondialdehyde level and severe preeclampsia.
Rahimi Z; Kazemian L; Malek-Khosravi S; Najafi F; Rahimi Z
Arch Gynecol Obstet; 2015 Jan; 291(1):45-51. PubMed ID: 25063248
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 gene polymorphisms in systemic lupus erythematosus: relation to disease status.
Fouad NA; Baraka EA; Hassan WA
Egypt J Immunol; 2014; 21(1):1-12. PubMed ID: 25204040
[TBL] [Abstract][Full Text] [Related]
16. Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus.
Faber-Elmann A; Sthoeger Z; Tcherniack A; Dayan M; Mozes E
Clin Exp Immunol; 2002 Feb; 127(2):393-8. PubMed ID: 11876767
[TBL] [Abstract][Full Text] [Related]
17. Role of MMP-2 and its inhibitor TIMP-2 as biomarkers for susceptibility to systemic lupus erythematosus.
Vira HJ; Pradhan VD; Umare VD; Chaudhary AK; Rajadhyksha AG; Nadkar MY; Ghosh K; Nadkarni AH
Biomark Med; 2020 Aug; 14(12):1109-1119. PubMed ID: 32969251
[No Abstract] [Full Text] [Related]
18. Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
Lesiak A; Narbutt J; Sysa-Jedrzejowska A; Lukamowicz J; McCauliffe DP; Wózniacka A
Lupus; 2010 May; 19(6):683-8. PubMed ID: 20064914
[TBL] [Abstract][Full Text] [Related]
19. Association analysis of genetic polymorphisms and expression levels of selected genes involved in extracellular matrix turnover and angiogenesis with the risk of age-related macular degeneration.
Oszajca K; Szemraj M; Szemraj J; Jurowski P
Ophthalmic Genet; 2018 Dec; 39(6):684-698. PubMed ID: 30289322
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
